Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

Published:2016-05-20 Issue:5 Volume:11 Page:e0151829
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mouzaki Marialena,Wang Alice Y.,Bandsma Robert,Comelli Elena M.,Arendt Bianca M.,Zhang Ling,Fung Scott,Fischer Sandra E.,McGilvray Ian G.,Allard Johane P.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Non-alcoholic fatty liver disease;N Sattar;BMJ,2014

2. From the metabolic syndrome to NAFLD or vice versa?;E Vanni;Digestive and liver Disease,2010

3. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008;ZM Younossi;Clinical Gastroenterology and Hepatology,2011

4. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;RJ Wong;Gastroenterology,2015

5. Microbiota‐liver axis in hepatic disease;B Chassaing;Hepatology,2014

Cited by 305 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice;Journal of Ethnopharmacology;2024-11

2. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease;Livers;2024-09-12

3. Bacteroides ovatus alleviates high-fat and high-cholesterol -induced nonalcoholic fatty liver disease via gut-liver axis;Biomedicine & Pharmacotherapy;2024-09

4. The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis;Obesity Medicine;2024-09

5. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15